MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines

Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to r...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 11; no. 1; pp. 14772 - 11
Main Authors Li, Su-Chen, Monazzam, Azita, Razmara, Masoud, Chu, Xia, Stålberg, Peter, Skogseid, Britt
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 20.07.2021
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice ( Men1 +/− ) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1 +/− compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies.
AbstractList Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1(+/-)) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1(+/-) compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies.
Abstract Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1 +/−) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1 +/− compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies.
Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice ( Men1 +/− ) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1 +/− compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies.
Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1+/-) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1+/- compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies.Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1+/-) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1+/- compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies.
Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1+/−) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1+/− compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies.
ArticleNumber 14772
Author Skogseid, Britt
Monazzam, Azita
Li, Su-Chen
Razmara, Masoud
Chu, Xia
Stålberg, Peter
Author_xml – sequence: 1
  givenname: Su-Chen
  surname: Li
  fullname: Li, Su-Chen
  organization: Department of Medical Sciences, Uppsala University
– sequence: 2
  givenname: Azita
  surname: Monazzam
  fullname: Monazzam, Azita
  organization: Department of Medical Sciences, Uppsala University
– sequence: 3
  givenname: Masoud
  surname: Razmara
  fullname: Razmara, Masoud
  organization: Department of Medical Sciences, Uppsala University
– sequence: 4
  givenname: Xia
  surname: Chu
  fullname: Chu, Xia
  organization: Department of Medical Sciences, Uppsala University
– sequence: 5
  givenname: Peter
  surname: Stålberg
  fullname: Stålberg, Peter
  organization: Department of Surgical Sciences, Uppsala University
– sequence: 6
  givenname: Britt
  surname: Skogseid
  fullname: Skogseid, Britt
  email: britt.skogseid@medsci.uu.se
  organization: Department of Medical Sciences, Uppsala University, Science for Life Laboratory in Uppsala
BackLink https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-456302$$DView record from Swedish Publication Index
BookMark eNp9ks9u1DAQxiNUREvpC3CyxIVDA44dZ-0LUtXyp1IBqQKu1sSebF0ldrATqvZ1eFGc3UXQHhpZysj-vt_YM_O82PPBY1G8rOibinL5NtWVULKkrCpVDuvy7klxwGgtSsYZ2_sv3i-OUrqm-RMsS9WzYp_XTIq8Dorfn91lWcum5CO5gURsuPER13MPE1oCExmcieHyywkZY-hc7_yahI6AjeihT0s8zP3kxh4JehtMdB6JxzD2kByQ6XZEUi0UPCbgLXH-yrVugV_NA_gtKZgQJ2egJwaicT4MQAz2Pcn5ML0onnY5Fx7t_ofF9w_vv51-Ki--fjw_PbkojRD1VAqJrbINY8BaUFI0Blaiba3N5bI0P1wq23HbGWiY6GqgbauA2qxVKKGj_LA433JtgGs9RjdAvNUBnN5shLjWsFyzR91yuaosrHi9UjXWIHnToqVgQSDrzCqzjresdIPj3N6jnbkfJxvaPOtaNJyyLH-3lWftgNagnyL091z3T7y70uvwS0umGG-aDHi9A8Twc8Y06cGlpYSQezEnzYTgslKNWnK9eiC9DnNcurlRcSVpvQDlVpXbn1LEThs3weTCkt_1uqJ6mUO9nUOd51Bv5lDfZSt7YP37jkdNfFewLPZrjP9u9YjrDy219PU
CitedBy_id crossref_primary_10_1080_15384047_2024_2428469
crossref_primary_10_7717_peerj_16930
crossref_primary_10_1002_mc_23879
crossref_primary_10_1097_MD_0000000000036908
crossref_primary_10_3389_fgene_2023_1137017
Cites_doi 10.1530/JME-18-0262
10.1038/ng.2953
10.1016/j.bbcan.2012.03.001
10.1038/nrg2843
10.1038/nature06487
10.1038/jid.2014.479
10.1136/gut.2006.108910
10.1210/jcem.84.1.5388
10.1016/j.humpath.2005.11.022
10.1371/journal.pone.0087951
10.1007/s13277-014-2412-0
10.1007/s11745-004-1329-9
10.1038/labinvest.2010.157
10.1210/en.2011-1924
10.1002/cncr.25724
10.1186/s12944-019-1058-8
10.1530/ERC-11-0082
10.1097/PAI.0000000000000117
10.1200/JCO.2005.05.5194
10.1126/science.276.5311.404
10.1016/0002-9343(54)90353-8
10.1210/jcem.75.1.1352309
10.1038/ng865
10.1002/hep.26662
10.3892/ol.2017.7598
10.1101/gad.949001
10.1210/jc.2014-3282
10.1128/mcb.23.17.6075-6085.2003
10.1073/pnas.011404098
10.1677/ERC-09-0096
10.1016/j.bbrc.2013.01.016
10.1093/nar/gkv007
10.1038/nrg1379
10.1158/0008-5472.CAN-11-4112
10.1006/meth.2001.1262
10.1002/ijc.22288
10.1158/1078-0432.CCR-10-3152
10.1016/j.ccell.2016.04.002
10.1210/jc.2018-00817
10.1038/onc.2009.192
10.1016/j.cell.2009.01.002
10.1016/j.bbrc.2011.02.065
10.1016/s0092-8674(04)00045-5
10.1158/0008-5472.CAN-09-3970
10.1158/0008-5472.CAN-10-3221
10.1007/s00423-006-0124-7
10.1111/j.2517-6161.1995.tb02031.x
10.3322/caac.21244
10.2202/1544-6115.1027
10.1530/EJE-11-0679
ContentType Journal Article
Copyright The Author(s) 2021
The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021. The Author(s).
Copyright_xml – notice: The Author(s) 2021
– notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021. The Author(s).
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
ACNBI
ADTPV
AOWAS
D8T
DF2
ZZAVC
DOA
DOI 10.1038/s41598-021-94154-z
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
SWEPUB Uppsala universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Uppsala universitet
SwePub Articles full text
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
Publicly Available Content Database
CrossRef

Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen Free (Free internet resource, activated by CARLI)
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 11
ExternalDocumentID oai_doaj_org_article_b3871da734794e4a836bed0ada5e2fc7
oai_DiVA_org_uu_456302
PMC8292366
10_1038_s41598_021_94154_z
GrantInformation_xml – fundername: Uppsala University
– fundername: Cancerfonden
  grantid: CAN 2017/768
  funderid: http://dx.doi.org/10.13039/501100002794
– fundername: Vetenskapsrådet
  grantid: 2015–4870
  funderid: http://dx.doi.org/10.13039/501100004359
– fundername: ;
– fundername: ;
  grantid: CAN 2017/768
– fundername: ;
  grantid: 2015–4870
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
7XB
8FK
AARCD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ACNBI
ADTPV
AOWAS
D8T
DF2
EJD
IPNFZ
RIG
ZZAVC
PUEGO
ID FETCH-LOGICAL-c554t-58eb9d622a2ba9856ca75bbdd038d041989df3dfca625f4a0bb9a0dba99e8af03
IEDL.DBID M48
ISSN 2045-2322
IngestDate Wed Aug 27 01:27:04 EDT 2025
Thu Aug 21 07:03:30 EDT 2025
Thu Aug 21 18:22:16 EDT 2025
Fri Jul 11 06:52:33 EDT 2025
Wed Aug 13 10:54:23 EDT 2025
Thu Apr 24 22:55:09 EDT 2025
Tue Jul 01 03:48:55 EDT 2025
Fri Feb 21 02:38:56 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c554t-58eb9d622a2ba9856ca75bbdd038d041989df3dfca625f4a0bb9a0dba99e8af03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-021-94154-z
PMID 34285285
PQID 2553398046
PQPubID 2041939
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_b3871da734794e4a836bed0ada5e2fc7
swepub_primary_oai_DiVA_org_uu_456302
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8292366
proquest_miscellaneous_2553819692
proquest_journals_2553398046
crossref_citationtrail_10_1038_s41598_021_94154_z
crossref_primary_10_1038_s41598_021_94154_z
springer_journals_10_1038_s41598_021_94154_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-07-20
PublicationDateYYYYMMDD 2021-07-20
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-20
  day: 20
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Wang (CR39) 2011; 71
Bartel (CR17) 2009; 136
CR37
Zecchin (CR47) 2011; 91
Pizer (CR45) 2000; 60
Heppner (CR8) 1999; 84
Doghman (CR30) 2010; 70
Loffler (CR5) 2007; 120
Crabtree (CR4) 2003; 23
Ritchie (CR49) 2015; 43
Livak, Schmittgen (CR52) 2001; 25
Zaidi, Swinnen, Smans (CR41) 2012; 72
Tian, Li, Sheng, Jin (CR42) 2018; 15
Wermer (CR1) 1954; 16
Waldmann (CR3) 2007; 392
Ozata (CR16) 2011; 18
Patterson, Holloway, Weng, Fojo, Kebebew (CR31) 2011; 117
Lim (CR27) 2014; 59
Roldo (CR19) 2006; 24
Decmann (CR36) 2018; 103
Park (CR26) 2011; 406
Zheng (CR10) 2016; 29
Zhang, Liu, Cui, Wang, Yang (CR33) 2014; 35
Penna, Orso, Taverna (CR38) 2015; 135
Nicolson, Korah, Carling (CR11) 2019; 62
Juhlin (CR14) 2015; 100
Chang (CR43) 2019; 18
Chandrasekharappa (CR6) 1997; 276
Zhang, Zhao, Gao, Zhang (CR35) 1826; 32–43
Shah (CR46) 2006; 37
Krol, Loedige, Filipowicz (CR18) 2010; 11
Bartel (CR22) 2004; 116
Lee (CR28) 2009; 28
Li, Wong (CR48) 2001; 98
CR50
Tombol (CR29) 2009; 16
Benjamini, Hochberg (CR51) 1995; 57
Skogseid (CR2) 1992; 75
Lai (CR21) 2002; 30
Li, Zhu, Xu, Wang, Yan (CR32) 2013; 431
Feinmesser (CR34) 2015; 23
Oh (CR40) 2011; 17
Assie (CR9) 2014; 46
CR25
CR24
Quon, Berns (CR7) 2001; 15
Lejonklou, Barbu, Stalberg, Skogseid (CR13) 2012; 153
Chirala, Wakil (CR44) 2004; 39
He, Hannon (CR23) 2004; 5
Kjellin (CR15) 2014; 9
Tavazoie (CR20) 2008; 451
Anlauf (CR12) 2007; 56
EE Patterson (94154_CR31) 2011; 117
L Lim (94154_CR27) 2014; 59
NG Nicolson (94154_CR11) 2019; 62
J Krol (94154_CR18) 2010; 11
ES Pizer (94154_CR45) 2000; 60
DP Bartel (94154_CR22) 2004; 116
Y Li (94154_CR32) 2013; 431
ME Ritchie (94154_CR49) 2015; 43
M Doghman (94154_CR30) 2010; 70
C Li (94154_CR48) 2001; 98
EC Lai (94154_CR21) 2002; 30
Y Wang (94154_CR39) 2011; 71
P Wermer (94154_CR1) 1954; 16
C Heppner (94154_CR8) 1999; 84
KJ Livak (94154_CR52) 2001; 25
L He (94154_CR23) 2004; 5
N Zaidi (94154_CR41) 2012; 72
JS Crabtree (94154_CR4) 2003; 23
S Tian (94154_CR42) 2018; 15
94154_CR50
SC Chandrasekharappa (94154_CR6) 1997; 276
H Kjellin (94154_CR15) 2014; 9
CC Juhlin (94154_CR14) 2015; 100
Z Tombol (94154_CR29) 2009; 16
US Shah (94154_CR46) 2006; 37
Y Benjamini (94154_CR51) 1995; 57
DP Bartel (94154_CR17) 2009; 136
L Chang (94154_CR43) 2019; 18
94154_CR24
KH Lee (94154_CR28) 2009; 28
94154_CR25
DM Ozata (94154_CR16) 2011; 18
M Feinmesser (94154_CR34) 2015; 23
KC Quon (94154_CR7) 2001; 15
C Roldo (94154_CR19) 2006; 24
SF Tavazoie (94154_CR20) 2008; 451
G Assie (94154_CR9) 2014; 46
MH Lejonklou (94154_CR13) 2012; 153
J Waldmann (94154_CR3) 2007; 392
HK Oh (94154_CR40) 2011; 17
KA Loffler (94154_CR5) 2007; 120
SS Chirala (94154_CR44) 2004; 39
B Skogseid (94154_CR2) 1992; 75
KG Zecchin (94154_CR47) 2011; 91
94154_CR37
M Anlauf (94154_CR12) 2007; 56
A Decmann (94154_CR36) 2018; 103
E Penna (94154_CR38) 2015; 135
G Zhang (94154_CR33) 2014; 35
S Zheng (94154_CR10) 2016; 29
J Zhang (94154_CR35) 1826; 32–43
JK Park (94154_CR26) 2011; 406
References_xml – volume: 62
  start-page: 179
  year: 2019
  end-page: 186
  ident: CR11
  article-title: Adrenocortical cancer cell line mutational profile reveals aggressive genetic background
  publication-title: J. Mol. Endocrinol.
  doi: 10.1530/JME-18-0262
– volume: 60
  start-page: 213
  year: 2000
  end-page: 218
  ident: CR45
  article-title: Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts
  publication-title: Cancer Res
– volume: 46
  start-page: 607
  year: 2014
  end-page: 612
  ident: CR9
  article-title: Integrated genomic characterization of adrenocortical carcinoma
  publication-title: Nat. Genet
  doi: 10.1038/ng.2953
– volume: 32–43
  start-page: 2012
  year: 1826
  ident: CR35
  article-title: Secretory miRNAs as novel cancer biomarkers
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbcan.2012.03.001
– volume: 11
  start-page: 597
  year: 2010
  end-page: 610
  ident: CR18
  article-title: The widespread regulation of microRNA biogenesis, function and decay
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg2843
– volume: 451
  start-page: 147
  year: 2008
  end-page: 152
  ident: CR20
  article-title: Endogenous human microRNAs that suppress breast cancer metastasis
  publication-title: Nature
  doi: 10.1038/nature06487
– volume: 135
  start-page: 960
  year: 2015
  end-page: 969
  ident: CR38
  article-title: miR-214 as a key hub that controls cancer networks: small player, multiple functions
  publication-title: J. Invest Dermatol.
  doi: 10.1038/jid.2014.479
– volume: 56
  start-page: 637
  year: 2007
  end-page: 644
  ident: CR12
  article-title: Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions
  publication-title: Gut
  doi: 10.1136/gut.2006.108910
– ident: CR25
– volume: 84
  start-page: 216
  year: 1999
  end-page: 219
  ident: CR8
  article-title: MEN1 gene analysis in sporadic adrenocortical neoplasms
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jcem.84.1.5388
– volume: 37
  start-page: 401
  year: 2006
  end-page: 409
  ident: CR46
  article-title: Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma
  publication-title: Hum. Pathol.
  doi: 10.1016/j.humpath.2005.11.022
– volume: 9
  year: 2014
  ident: CR15
  article-title: Differentially expressed proteins in malignant and benign adrenocortical tumors
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0087951
– volume: 35
  start-page: 11137
  year: 2014
  end-page: 11145
  ident: CR33
  article-title: MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells
  publication-title: Tumour Biol.
  doi: 10.1007/s13277-014-2412-0
– volume: 39
  start-page: 1045
  year: 2004
  end-page: 1053
  ident: CR44
  article-title: Structure and function of animal fatty acid synthase
  publication-title: Lipids
  doi: 10.1007/s11745-004-1329-9
– volume: 91
  start-page: 232
  year: 2011
  end-page: 240
  ident: CR47
  article-title: Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis
  publication-title: Lab Invest.
  doi: 10.1038/labinvest.2010.157
– volume: 153
  start-page: 2588
  year: 2012
  end-page: 2598
  ident: CR13
  article-title: Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor
  publication-title: Endocrinology
  doi: 10.1210/en.2011-1924
– ident: CR50
– volume: 117
  start-page: 1630
  year: 2011
  end-page: 1639
  ident: CR31
  article-title: MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy
  publication-title: Cancer
  doi: 10.1002/cncr.25724
– volume: 18
  start-page: 118
  year: 2019
  ident: CR43
  article-title: Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway
  publication-title: Lipids Health Dis.
  doi: 10.1186/s12944-019-1058-8
– volume: 18
  start-page: 643
  year: 2011
  end-page: 655
  ident: CR16
  article-title: The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
  publication-title: Endocr. Relat. Cancer
  doi: 10.1530/ERC-11-0082
– volume: 23
  start-page: 522
  year: 2015
  end-page: 531
  ident: CR34
  article-title: Specific microRNAs differentiate adrenocortical adenomas from carcinomas and correlate with weiss histopathologic system
  publication-title: Appl Immunohistochem Mol Morphol
  doi: 10.1097/PAI.0000000000000117
– volume: 24
  start-page: 4677
  year: 2006
  end-page: 4684
  ident: CR19
  article-title: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2005.05.5194
– volume: 276
  start-page: 404
  year: 1997
  end-page: 407
  ident: CR6
  article-title: Positional cloning of the gene for multiple endocrine neoplasia-type 1
  publication-title: Science
  doi: 10.1126/science.276.5311.404
– volume: 16
  start-page: 363
  year: 1954
  end-page: 371
  ident: CR1
  article-title: Genetic aspects of adenomatosis of endocrine glands
  publication-title: Am. J. Med.
  doi: 10.1016/0002-9343(54)90353-8
– volume: 75
  start-page: 76
  year: 1992
  end-page: 81
  ident: CR2
  article-title: Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jcem.75.1.1352309
– volume: 30
  start-page: 363
  year: 2002
  end-page: 364
  ident: CR21
  article-title: Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation
  publication-title: Nat. Genet.
  doi: 10.1038/ng865
– volume: 59
  start-page: 202
  year: 2014
  end-page: 215
  ident: CR27
  article-title: MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer
  publication-title: Hepatology
  doi: 10.1002/hep.26662
– ident: CR37
– volume: 15
  start-page: 2211
  year: 2018
  end-page: 2217
  ident: CR42
  article-title: Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2017.7598
– volume: 15
  start-page: 2917
  year: 2001
  end-page: 2921
  ident: CR7
  article-title: Haplo-insufficiency? Let me count the ways
  publication-title: Genes Dev.
  doi: 10.1101/gad.949001
– volume: 100
  start-page: E493
  year: 2015
  end-page: 502
  ident: CR14
  article-title: Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2014-3282
– volume: 23
  start-page: 6075
  year: 2003
  end-page: 6085
  ident: CR4
  article-title: Of mice and MEN1: Insulinomas in a conditional mouse knockout
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/mcb.23.17.6075-6085.2003
– volume: 98
  start-page: 31
  year: 2001
  end-page: 36
  ident: CR48
  article-title: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection
  publication-title: Proc. Natl. Acad. Sci. U S A
  doi: 10.1073/pnas.011404098
– volume: 57
  start-page: 289
  year: 1995
  end-page: 300
  ident: CR51
  article-title: Controlling the false discovery rate: a practical and powerful approach to multiple testing
  publication-title: J R Stat Soc B
– volume: 16
  start-page: 895
  year: 2009
  end-page: 906
  ident: CR29
  article-title: Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis
  publication-title: Endocr. Relat. Cancer
  doi: 10.1677/ERC-09-0096
– volume: 431
  start-page: 560
  year: 2013
  end-page: 565
  ident: CR32
  article-title: miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2013.01.016
– volume: 43
  year: 2015
  ident: CR49
  article-title: limma powers differential expression analyses for RNA-sequencing and microarray studies
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv007
– volume: 5
  start-page: 522
  year: 2004
  end-page: 531
  ident: CR23
  article-title: MicroRNAs: small RNAs with a big role in gene regulation
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg1379
– volume: 72
  start-page: 3709
  year: 2012
  end-page: 3714
  ident: CR41
  article-title: ATP-citrate lyase: a key player in cancer metabolism
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-11-4112
– volume: 25
  start-page: 402
  year: 2001
  end-page: 408
  ident: CR52
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 120
  start-page: 259
  year: 2007
  end-page: 267
  ident: CR5
  article-title: Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.22288
– volume: 17
  start-page: 2657
  year: 2011
  end-page: 2667
  ident: CR40
  article-title: Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-3152
– volume: 29
  start-page: 723
  year: 2016
  end-page: 736
  ident: CR10
  article-title: Comprehensive pan-genomic characterization of adrenocortical carcinoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.04.002
– volume: 103
  start-page: 3522
  year: 2018
  end-page: 3530
  ident: CR36
  article-title: MicroRNA expression profiling in adrenal myelolipoma
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2018-00817
– volume: 28
  start-page: 3360
  year: 2009
  end-page: 3370
  ident: CR28
  article-title: MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation
  publication-title: Oncogene
  doi: 10.1038/onc.2009.192
– volume: 136
  start-page: 215
  year: 2009
  end-page: 233
  ident: CR17
  article-title: MicroRNAs: target recognition and regulatory functions
  publication-title: Cell
  doi: 10.1016/j.cell.2009.01.002
– volume: 406
  start-page: 518
  year: 2011
  end-page: 523
  ident: CR26
  article-title: miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2011.02.065
– volume: 116
  start-page: 281
  year: 2004
  end-page: 297
  ident: CR22
  article-title: MicroRNAs: genomics, biogenesis, mechanism, and function
  publication-title: Cell
  doi: 10.1016/s0092-8674(04)00045-5
– volume: 70
  start-page: 4666
  year: 2010
  end-page: 4675
  ident: CR30
  article-title: Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-3970
– ident: CR24
– volume: 71
  start-page: 371
  year: 2011
  end-page: 382
  ident: CR39
  article-title: The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-3221
– volume: 392
  start-page: 437
  year: 2007
  end-page: 443
  ident: CR3
  article-title: Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening
  publication-title: Langenbecks Arch Surg
  doi: 10.1007/s00423-006-0124-7
– volume: 100
  start-page: E493
  year: 2015
  ident: 94154_CR14
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2014-3282
– volume: 24
  start-page: 4677
  year: 2006
  ident: 94154_CR19
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2005.05.5194
– volume: 431
  start-page: 560
  year: 2013
  ident: 94154_CR32
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2013.01.016
– volume: 30
  start-page: 363
  year: 2002
  ident: 94154_CR21
  publication-title: Nat. Genet.
  doi: 10.1038/ng865
– volume: 25
  start-page: 402
  year: 2001
  ident: 94154_CR52
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 71
  start-page: 371
  year: 2011
  ident: 94154_CR39
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-3221
– volume: 18
  start-page: 118
  year: 2019
  ident: 94154_CR43
  publication-title: Lipids Health Dis.
  doi: 10.1186/s12944-019-1058-8
– volume: 23
  start-page: 522
  year: 2015
  ident: 94154_CR34
  publication-title: Appl Immunohistochem Mol Morphol
  doi: 10.1097/PAI.0000000000000117
– volume: 75
  start-page: 76
  year: 1992
  ident: 94154_CR2
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jcem.75.1.1352309
– volume: 392
  start-page: 437
  year: 2007
  ident: 94154_CR3
  publication-title: Langenbecks Arch Surg
  doi: 10.1007/s00423-006-0124-7
– volume: 103
  start-page: 3522
  year: 2018
  ident: 94154_CR36
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2018-00817
– volume: 32–43
  start-page: 2012
  year: 1826
  ident: 94154_CR35
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbcan.2012.03.001
– volume: 57
  start-page: 289
  year: 1995
  ident: 94154_CR51
  publication-title: J R Stat Soc B
  doi: 10.1111/j.2517-6161.1995.tb02031.x
– volume: 37
  start-page: 401
  year: 2006
  ident: 94154_CR46
  publication-title: Hum. Pathol.
  doi: 10.1016/j.humpath.2005.11.022
– volume: 406
  start-page: 518
  year: 2011
  ident: 94154_CR26
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2011.02.065
– volume: 84
  start-page: 216
  year: 1999
  ident: 94154_CR8
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jcem.84.1.5388
– volume: 9
  year: 2014
  ident: 94154_CR15
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0087951
– volume: 117
  start-page: 1630
  year: 2011
  ident: 94154_CR31
  publication-title: Cancer
  doi: 10.1002/cncr.25724
– volume: 276
  start-page: 404
  year: 1997
  ident: 94154_CR6
  publication-title: Science
  doi: 10.1126/science.276.5311.404
– ident: 94154_CR24
– volume: 16
  start-page: 363
  year: 1954
  ident: 94154_CR1
  publication-title: Am. J. Med.
  doi: 10.1016/0002-9343(54)90353-8
– volume: 70
  start-page: 4666
  year: 2010
  ident: 94154_CR30
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-3970
– volume: 29
  start-page: 723
  year: 2016
  ident: 94154_CR10
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.04.002
– volume: 451
  start-page: 147
  year: 2008
  ident: 94154_CR20
  publication-title: Nature
  doi: 10.1038/nature06487
– volume: 135
  start-page: 960
  year: 2015
  ident: 94154_CR38
  publication-title: J. Invest Dermatol.
  doi: 10.1038/jid.2014.479
– volume: 5
  start-page: 522
  year: 2004
  ident: 94154_CR23
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg1379
– ident: 94154_CR25
  doi: 10.3322/caac.21244
– volume: 39
  start-page: 1045
  year: 2004
  ident: 94154_CR44
  publication-title: Lipids
  doi: 10.1007/s11745-004-1329-9
– volume: 15
  start-page: 2917
  year: 2001
  ident: 94154_CR7
  publication-title: Genes Dev.
  doi: 10.1101/gad.949001
– volume: 59
  start-page: 202
  year: 2014
  ident: 94154_CR27
  publication-title: Hepatology
  doi: 10.1002/hep.26662
– volume: 98
  start-page: 31
  year: 2001
  ident: 94154_CR48
  publication-title: Proc. Natl. Acad. Sci. U S A
  doi: 10.1073/pnas.011404098
– volume: 15
  start-page: 2211
  year: 2018
  ident: 94154_CR42
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2017.7598
– volume: 23
  start-page: 6075
  year: 2003
  ident: 94154_CR4
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/mcb.23.17.6075-6085.2003
– volume: 91
  start-page: 232
  year: 2011
  ident: 94154_CR47
  publication-title: Lab Invest.
  doi: 10.1038/labinvest.2010.157
– volume: 72
  start-page: 3709
  year: 2012
  ident: 94154_CR41
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-11-4112
– volume: 60
  start-page: 213
  year: 2000
  ident: 94154_CR45
  publication-title: Cancer Res
– volume: 116
  start-page: 281
  year: 2004
  ident: 94154_CR22
  publication-title: Cell
  doi: 10.1016/s0092-8674(04)00045-5
– volume: 43
  year: 2015
  ident: 94154_CR49
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv007
– volume: 11
  start-page: 597
  year: 2010
  ident: 94154_CR18
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg2843
– volume: 62
  start-page: 179
  year: 2019
  ident: 94154_CR11
  publication-title: J. Mol. Endocrinol.
  doi: 10.1530/JME-18-0262
– volume: 18
  start-page: 643
  year: 2011
  ident: 94154_CR16
  publication-title: Endocr. Relat. Cancer
  doi: 10.1530/ERC-11-0082
– ident: 94154_CR50
  doi: 10.2202/1544-6115.1027
– volume: 153
  start-page: 2588
  year: 2012
  ident: 94154_CR13
  publication-title: Endocrinology
  doi: 10.1210/en.2011-1924
– ident: 94154_CR37
  doi: 10.1530/EJE-11-0679
– volume: 56
  start-page: 637
  year: 2007
  ident: 94154_CR12
  publication-title: Gut
  doi: 10.1136/gut.2006.108910
– volume: 120
  start-page: 259
  year: 2007
  ident: 94154_CR5
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.22288
– volume: 46
  start-page: 607
  year: 2014
  ident: 94154_CR9
  publication-title: Nat. Genet
  doi: 10.1038/ng.2953
– volume: 16
  start-page: 895
  year: 2009
  ident: 94154_CR29
  publication-title: Endocr. Relat. Cancer
  doi: 10.1677/ERC-09-0096
– volume: 17
  start-page: 2657
  year: 2011
  ident: 94154_CR40
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-3152
– volume: 136
  start-page: 215
  year: 2009
  ident: 94154_CR17
  publication-title: Cell
  doi: 10.1016/j.cell.2009.01.002
– volume: 28
  start-page: 3360
  year: 2009
  ident: 94154_CR28
  publication-title: Oncogene
  doi: 10.1038/onc.2009.192
– volume: 35
  start-page: 11137
  year: 2014
  ident: 94154_CR33
  publication-title: Tumour Biol.
  doi: 10.1007/s13277-014-2412-0
SSID ssj0000529419
Score 2.3818014
Snippet Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant...
Abstract Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in...
SourceID doaj
swepub
pubmedcentral
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 14772
SubjectTerms 631/337
631/67
Acid production
Cancer
Fatty acids
Fatty-acid synthase
Gene expression
Genetic transformation
Humanities and Social Sciences
Inactivation
Lipid metabolism
MicroRNAs
Mimicry
miRNA
multidisciplinary
Multiple endocrine neoplasia
Neuroendocrine tumors
Nucleic acids
Palmitic acid
Pancreas
Parathyroid
Pituitary
Science
Science (multidisciplinary)
Surgery
Transcription
Transfection
Tumor cell lines
Tumorigenesis
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiKcIFGQkONGoie04znF5VBVSe6go6s2yM44aiSZVd1eI_h3-KDN2dml6KBduUeLYzjziGXvmG8beCd11nW5UruoWcmUUqpSsy1zICnTpVZBxK_voWB-eqq9n1dmNUl8UE5bggRPh9r1Ekx5cTRmPKihnpPYBCgeuCqJrYx45rnk3nKmE6i0aVTZTlkwhzf4SVyrKJqOIBLxU-fVsJYqA_TMr83aM5Pag9BaoaFyIDh6xh5MFyRdp5o_ZvTA8YfdTTclfT9nvo_4EqaFzecl_uiUHdLOvUsH5ANyt-AWF4J0cL3gq142D8bHjjjK6URTpehNkyMMAY0vpgXygQHNKuOS0Z8tL6iXscTcA74fz3pPhymO9v9TTiE5t3CXnLRUrGsYLx-mMgJNVu3zGTg--fPt0mE-VGPIWzY1VXpngG9BCOOFdYyrdurryHgApC4WiuCvoJHStQ3eqU67wvnEFYNsmGNcV8jnbGcYhvGAc0AN0SuNvBhoV0Q69QBvHF1CjYDiTsXLDFdtOMOVULeOHjcfl0tjESYuctJGT9jpjH7bvXCaQjjtbfyRmb1sSwHa8gWJnJ7Gz_xK7jO1uRMVOWr-06J5J2ZhC6Yy93T5GfSUCO-TUOrUxhEkkMlbPRGw2ofmToT-PyN9GoD2usfe9jTD-HfyuD36fBHY2wuf--yJ-8nptFaHEiZf_gzCv2ANBSlbU-APeZTurq3V4jXbbyr-JKvoH13RCPw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4ilCCzISnGjUxHZi54SWR1UhtYeKor1ZduzQSDRZNruq6N_hjzLjPKr0sLdo47Vjz4w9M575hpD3LK-qKi9ELGTpYqEEiBSXacx45vLUCs-DK_v0LD-5EN-X2XJwuHVDWOW4J4aN2rUl-siPQPXlvFBgzn1a_YmxahTerg4lNO6TBwhdhiFdciknHwveYom0GHJlEq6OOjivMKcM4xLgUcQ3s_MowPbPdM27kZLTdekdaNFwHB0_IY8HPZIuesI_Jfd884w87CtL_n1O_p3W57AmecxX9Np01IGxve7LzntHzYZeYSDe-dmC9kW7YTDaVtRgXjcwJD6PoYbUN7A6mCRIGww3x7RLip5bmmIv_pCaxtG6uawtqq80VP3re2rBtA2-clpiyaKmvTIUbwoo6rbdC3Jx_O3Hl5N4qMcQl6B0bOJMeVu4nDHDrClUlpdGZtY6ByvrEoHRV67irioNGFWVMIm1hUkctC28MlXCX5K9pm38K0Id2IFG5LDZuEIEzEPLQNOxiZPAHkZFJB2possBrBxrZvzW4dKcK91TUgMldaCkvonIx-k_qx6qY2frz0jsqSXCbIcf2vUvPUitthzsSWckptsKL4ziufUuMc5knlWljMjByCp6kP1O33JqRN5Nr0FqcYENUGrbt1GITMQiImcsNvug-Zumvgz434qBVp5D74cjM94OvmvCH3qGnY3wtf65CFPebrVArDj2evec9skjhuKTSNhgD8jeZr31b0Av29i3Qfj-A7c3OOw
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ba9YwFA9zIvgiXrFuSgR9csU2SdP08fPTMYTtYTjZW0ia1BVcOr4Lsv07_qOek16kQwa-hTaXNuec5JzknN8h5B2TTdPISqSirF0qlACR4mWeMl44mVvheTzKPj6RR2fi63lxvkPYGAsTnfYjpGVcpkfvsI9r2GgwGAwdCqAo0pt75D5CtyNXL-VyOlfBmyuRV0N8TMbVP5rO9qAI1T_TL297R05XpLfgROMWdPiYPBp0R7rov_YJ2fHhKXnQZ5O8fkZ-H7enMA8y5Vf0l1lTBwb2qk817x01G3qJznenJwvaJ-qGwWjXUIOx3MCEWB7dC6kPrqsxMJAGdDHHUEuKp7U0x178ATXB0TZctBZVVhoz_fU9dWDOxvNxWmOaotBdGoq3AxT12fVzcnb45dvyKB1yMKQ1KBqbtFDeVk4yZpg1lSpkbcrCWudgZl0m0OPKNdw1tQFDqhEms7YymYO6lVemyfgLshu64F8S6sD2M0LCAuMqEXEOLQPtxmauBJYwKiH5SBVdDwDlmCfjp44X5VzpnpIaKKkjJfVNQj5Mba56eI47a39CYk81EVo7PuhWP_TAatpysCGdKTHEVnhhFJfWu8w4U3jW1GVC9kdW0YO8rzUYZpxXKhMyIW-n1yCpOMEGKLXt6yhEI2IJKWcsNvug-ZvQXkTMb8VAE5fQ-8HIjH8Hv-uH3_cMOxvhc_t9EX95u9UC8eHYq__rdo88ZChOWQmL7D7Z3ay2_jXoZhv7JgrjH_LrN0Q
  priority: 102
  providerName: Springer Nature
Title MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines
URI https://link.springer.com/article/10.1038/s41598-021-94154-z
https://www.proquest.com/docview/2553398046
https://www.proquest.com/docview/2553819692
https://pubmed.ncbi.nlm.nih.gov/PMC8292366
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-456302
https://doaj.org/article/b3871da734794e4a836bed0ada5e2fc7
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELf2ISReEJ8iMCojwRMLpI7jOA8IdWXTVKkVKhT1LbJjh1XaktEPwfbv8I9yZydFmaZJPCVKLnbiu4vv7LvfEfKGibIsRcZDnhYm5JKDSsVpP2RxYkRfcxu7pezxRJzO-GiezHdIW-6oGcDVra4d1pOaLc_f__559QkU_qNPGZcfVjAJYaIYBhvAKQ-vd8k-zEwpKuq4Mfc91jcDgqzJnbn90c785GD8O7bnzcjJ7fbpDahRNz2dPCQPGruSDrwgPCI7tnpM7vlKk1dPyJ_xYgpjJML4kv5SK2rA-V76MvTWULWmFxiYN50MqC_iDZ3RuqQK87xhoPC8DT2ktjJ1gUmDtMLwc0zDpLiSS_vYij2kqjJ0UZ0tNJqz1FUB9C3V4Oq6tXNaYAmjqr5QFHcOKNq6q6dkdnL8bXgaNvUZwgKMkHWYSKszIxhTTKtMJqJQaaK1MTCyJuIYjWXK2JSFAier5CrSOlORAdrMSlVG8TOyV9WVfU6oAb9QcQE_H5Nxh4GoGVg-OjIpiIuSAem3XMmLBrwca2ic524TPZa552QOnMwdJ_PrgLzbPnPpoTvupD5CZm8pEXbbXaiXP_JGi3Mdg39pVIrpt9xyJWOhrYmUUYllZZEG5KAVlbwV5RyctjjOZMRFQF5vb4MW4wAr4NTG00hEKmIBSTsi1nmh7p1qcebwwCUDK11A64etMP7r_K4PfusFttPD58X3gfvkzSbniB3HXvxfsy_JfYbqFKXwAz4ge-vlxr4Cu22te2Q3nac9sj8YjL6O4Hh0PPkyhatDMey5tZCeU9e_rllGwQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwQviE9RGGAk9sSipbaTOA8IdWzTxtYKVRvam2fHDqvEktIPTdu_wzt_I3dO0il76NveosY91_3dne_s-yDkE4vzPI9TEYgks4GQAkSKJ72A8cjGPSMc90fZg2F8cCq-n0Vna-RfkwuDYZWNTvSK2pYZnpFvg-nLeSrBnfs6-RNg1yi8XW1aaFRsceSur8Blm3053AV8Nxnb3zv5dhDUXQWCDLbOeRBJZ1IbM6aZ0amM4kwnkTHWhlzaUGAMkc25zTMNrkEudGhMqkMLY1MndR5yoPuArAsOrkyHrO_sDX-Mlqc6eG8GJOrsHKC4PYMdErPYMBICHkVw09oBfaOAlnV7NzZzeUF7p5ip3wD3n5InteVK-xWrPSNrrnhOHla9LK9fkL-D8QhQiAM-oVd6Ri2499Oq0b2zVM_pJYb-jYZ9WrUJh8lomVONmeQgAvjcBDdSVwAemJZICwxwx0RPimfFtIdU3BbVhaXj4mJs0GCmvs9gRakEZ9qfztMMmyQV5aWmeDdB0ZqevSSn94LVK9IpysK9JtQCXFrEoN5sKnyVRcPAtjKhTYAhteySXoOKyury6Nil47fy1_RcqgpJBUgqj6S66ZLPy-9MquIgK0fvINjLkVjY239QTn-pWk8ow8GDtTrBBF_hhJY8Ns6G2urIsTxLumSjYRVVa5uZupWNLvm4fA16Av9gDUgtqjESayGxLklaLNb6Qe03xfjCVxyXDPyAGKhvNcx4O_mqBW9WDNuaYXf8s--XvFgogdXp2JvVa_pAHh2cDI7V8eHw6C15zFCUwgTU-wbpzKcL9w6swrl5X4siJef3Lf3_ARggeTU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1BpDIF4QV1EYYCT2xKKlthM7DwgVSrUxVqGJob0ZO3ZYJZaUXjRtv8Nf8HWc4ySdsoe-7S1q3OO65-JzP4S8ZWlRFGkmIiFzFwklgKW47EeMJy7tW-F5cGUfjtO9Y_HlJDnZIP_aWhhMq2xlYhDUrsrRR74Lqi_nmcKIZNGkRXwbjj5M_0Q4QQojre04jZpEDvzFOZhv8_f7Q8D1NmOjz98_7UXNhIEoh2t0ESXK28yljBlmTaaSNDcysda5mCsXC8wncgV3RW7ATCiEia3NTOxgbeaVKWIOcG-R25InfeQxeSJX_h2MoAGApk4H4O3O4a7EejbMiYBHEV127sIwMqCj517P0lyFaq-1NQ1X4egBud_osHRQE91DsuHLR-ROPdXy4jH5ezg5AnykEZ_SczOnDgz9WT3y3jtqFvQMkwCPxgNaDwyHzWhVUIM15cAM-NymOVJfAmawQJGWmOqOJZ8Uvca0j1D8DjWlo5PydGJRdaZh4mANqQKzOvjpaY7jksrqzFCMUlDUq-dPyPGNYOop2Syr0j8j1IENakQKgs5lIvRbtAy0LBs7CaRpVI_0W6zovGmUjvM6fusQsOdK15jUgEkdMKkve-Td6jvTuk3I2tUfEdmrldjiO3xQzX7pRmJoy8GWdUZiqa_wwiieWu9i40ziWZHLHtlqSUU3cmeur7ikR96sXoPEwD_YAKaW9RqFXZFYj8gOiXV-UPdNOTkNvccVA4sgBeg7LTFebb7uwNs1wXZ2GE5-DMKRl0stsE8de77-TK_JXeB5_XV_fPCC3GPISbEEOb9FNhezpX8J6uHCvgp8SMnPm2b8_ynufAU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MiR-486-3p+was+downregulated+at+microRNA+profiling+of+adrenals+of+multiple+endocrine+neoplasia+type+1+mice%2C+and+inhibited+human+adrenocortical+carcinoma+cell+lines&rft.jtitle=Scientific+reports&rft.au=Li%2C+Su-Chen&rft.au=Monazzam%2C+Azita&rft.au=Razmara%2C+Masoud&rft.au=Chu%2C+Xia&rft.date=2021-07-20&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-021-94154-z&rft.externalDocID=10_1038_s41598_021_94154_z
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon